The UK's National Screening Committee has recommended that only a very small group of men at high risk of prostate cancer ...
One of the biggest advances in pancreatic cancer in decades came out of a crazy idea born in a Harvard University lab.
A whole-food plant-based diet can significantly increase weight loss for men with prostate cancer and overweight or obesity ...
Johnson & Johnson's Erleada drug, combined with hormone therapy, significantly reduces the risk of prostate cancer spread and ...
The foundation asked for $6.4 million over four years in Budget 2026 to fund two regional pilots for the early detection ...
Johnson & Johnson (NYSE:JNJ) today announced results from the final analysis of the Phase 3 PROTEUS study showing the investigational use of apalutamide plus hormone therapy (androgen deprivation ...
Johnson & Johnson's prostate cancer drug Erleada, reportedly used alongside standard home-blocking therapy before and after ...
Compared with patients receiving hormone therapy alone, patients were nine times more likely to have little to no cancer remaining in the prostate after surgery, with a 20 percent reduction in the ris ...
In her forthcoming memoir, former First Lady Jill Biden candidly addresses former President Joe Biden's stage IV prostate ...
Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We ...
Only men with a dangerous genetic variant and a family history of cancer should be offered screening, say UK advisors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results